SFL to exhibit at 2021 SwAPP/SGPM annual meeting
SFL’s Head of Regulatory Affairs and Deputy CEO, Anja Bührer, and SFL’s Business Development Manager, Delphine Guérin, will be attending the 26th annual meeting of the Swiss Association of Pharmaceutical Professionals (SwAPP) and the Swiss Society of Pharmaceutical Medicine (SGPM) in Zurich on 17 November. The event is titled ‘Expediting Drug Discovery and Development through Translational Medicine’. The programme includes presentations on data science, non-clinical testing, optimization of clinical trials and regulatory aspects, among others.
SFL is proud to sponsor this year’s event and exhibit onsite. SFL supports companies with their own drug development and throughout the lifecycle of the product. We encourage you to visit us at our booth to discover our services and how we can support your company.